On May 16th, 8 key construction projects in the Zhangjin District, Jinan's High-tech Innovation Service Center were started. Yinfeng Biotechnology Park was one of the key projects. Wang Hongzhi, a Member of CPC Jinan Municipal Committee and director of the Management Committee of the High-tech Zone, conducted field research on the project that has been started. Wang Wei, Chairman of Shandong Yinfeng Group, Zuo Hongbin, Vice President, Song Xianshou, President of Yinfeng Biotechnology Group, and Liu Linlin, Director of the Integrated Management Department attended the ceremony.

There are  8 projects to be started in total, including the Intelligent Transportation Industrial Park, Yinfeng Biotechnology Park, Bo Ke Bio-incubator R&D and manufacturing base and group headquarters, the Red Star Macalline commercial complex, and Jinniu Biotechnology serum, culture medium and production, scientific research projects of microbial agent, Shandong Shifang Construction Machinery Remanufacturing Project, Xinghui NC Non-metal Material CNC Machining Center, and Shandong Weizhen Human Genome Gene Biotechnology Reagent Project. Among them, there are 2 municipal key projects and 6 district-level key projects.

Yinfeng Bioengineering Science Park is an important investment of Yinfeng Biotechnology Group in biomedical field. The park covers an area of 55.32 acres, a total investment of 600 million yuan, a total construction area of over 120,000 square meters, aboveground volume ratio of 2.95, and a building density of 42.1%. The project is listed as a key project in the High-tech Zone in 2018. It is mainly focused on high-precision Biotechnology production buildings, supporting service buildings and ancillary facilities for the research and application of stem cell collection and treatment, cord blood storage, and human liquid nitrogen freezing. The project will make it as the top-ranking biotech park within the country. After the project is completed and put into production, it is estimated that the annual sales income can be up to 640 million yuan, and the annual tax payment will be 72 million yuan.

Yinfeng Biotechnology Group has been deeply cultivating in biomedical fields for more than 20 years and has achieved outstanding results in the life sciences. The Yinfeng Bio-Science Park project has gathered the international advanced Biotechnology and pharmaceutical research achievements together. Its completion will further expand the industrial layout, pilot the development of the domestic bio-pharmaceutical industry, help the transformation between the old and new energy to complete, and make greater contribution to the leap-forward development of high-tech district.